China Shineway Pharmaceutical Group Limited is an investment holding company. It is engaged in the research, development, manufacture and trading of modern Chinese medicines. Its Qing Kai Ling Injection is an anti-viral medicine for treatment of viral diseases, including respiratory tract infection, viral hepatitis, cerebral haemorrhage and cerebral thrombosis. Its Shu Xie Ning Injection is used for the treatment of cardio-cerebrovascular disease. Its Wu Fu Xin Nao Qing Soft Capsule is used for the prevention and treatment of coronary heart disease and cerebral arteriosclerosis. Its Pediatric Qing Fei Hua Tan Granule is used for children infected by respiratory related disease. Its other products include Huo Xiang Zheng Qi Soft Capsule, Huang Qi Injection and Qing Kai Ling Soft Capsule. In April 2010, it acquired Zhangjiakou Changcheng Pharmaceutical Limited and Sichuan Kalituo Pharmaceutical Limited, together with its wholly owned subsidiary Chengdu Kalituo Technology Company Limited.